Schrodinger, Inc. ($SDGR)
Akinsanya Karen โ President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
1,366
Price
$12.90
Total Value
$17,625.50
Nearby Earnings
Feb 25, 2026
EPS:Est: -0.13
Transaction Details
| Insider | Akinsanya Karen |
|---|---|
| Title | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
| Transaction Date | Mar 5, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Sold | 1,366 |
| Price per Share | $12.90 |
| Total Value | $17,625.50 |
| Shares Owned After | 69,956 |
| Derivative | No |
| Accession Number | 0001797672-26-000002 |
| Document | View SEC Filing |